Why some investors aren't thrilled about Becton Dickinson buying C.R. Bard
There's a mega-merger in the medical supply and device industry: Becton Dickinson is buying C-R Bard for $24 billion, creating a giant selling everything from syringes to catheters to infection-prevention technology.